NCT03535259
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
- Locations
-
- Bo Chen Beijing, Beijing Municipality, China
Clinical trial condition
Explore clinical trials studying Hepatocellular Carcinoma, Radiotherapy, Sorafenib. Study availability and eligibility vary by location and protocol.
NCT03535259